Turkish Neonatal Society guideline on the management of patent ductus arteriosus in preterm infants


Koksal N. , Aygun C., Uras N.

TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS, vol.53, 2018 (Journal Indexed in ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 53
  • Publication Date: 2018
  • Doi Number: 10.5152/turkpediatriars.2018.01808
  • Title of Journal : TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS
  • Keywords: Diagnosis, patent ductus arteriosus, preterm, treatment, BLOOD-FLOW, IBUPROFEN, INDOMETHACIN, ASSOCIATION, MORTALITY, DIAGNOSIS, PERFUSION, CLOSURE, SHUNT

Abstract

Ductus arteriosus is a physiologic phenomenon in utero and it closes spontaneously in term babies. The closure is problematic in preterm infants due to the intrinsic properties of the preterm ductus arteriosus tissue. Although patent ductus arteriosus has been reported to be associated with many adverse outcomes in this population, treatment has not led to a decrease in outcomes such as bronchopulmonary dysplasia. Treatment modalities also have their own risks and restrictions. The aim of the "Turkish Neonatal Society guidelines for the management of patent ductus arteriosus in preterm babies" is to standardize the diagnosis and treatment of patent ductus arteriosus in preterm infants by combining the current scientific data and the resources of our country.